All Articles

Wealth Enhancement's latest acquisition is more than a number. It’s a story of industry consolidation, operational pressures, and the future of client advice.

A new joint venture sees automotive giant Toyota apply its legendary production system to Joby's eVTOLs, a move that could finally unlock the era of air taxis.

Lahontan Gold is de-risking its Santa Fe Mine restart with a savvy brownfield strategy, key permitting wins, and innovative plans to reprocess historic waste.

As cyber and financial risks intensify, Markel bets on insider Bhavik Desai to lead its PFR & Cyber unit, signaling a strategic focus on disciplined growth.

New data shows a 201% surge in heartworm cases, signaling a major shift. This creates new risks and opportunities in vet pharma and pet insurance.

Novocure's Optune Pax device, using Tumor Treating Fields, gains European approval, offering extended survival and significant pain relief for a deadly disease.

A new partnership fuses satellite imagery with ground-truth data, offering unprecedented clarity into the chaotic, high-stakes world of data center construction.

Ambi Robotics and Pickle Robot have integrated their specialized AI systems, offering a landmark end-to-end solution to automate the entire inbound logistics workflow.

Emerita Resources pushes back its key feasibility study, betting on new tech for higher returns. But with a history of legal battles, is this a strategic pause?

A new $2.5 million federal investment in a world championship is more than a sports grant; it's a calculated move in Canada's long-term economic and diplomatic strategy.

A new Pearson and AWS report reveals a shocking gap. While 80% of students use AI, employers find they lack the real-world skills to apply it, creating a crisis in workforce readiness.

A new research hub is testing megawatt chargers for electric trucks. The real innovation is the software preventing a grid meltdown. Here's how it works.

Packsize's latest acquisition of Italian firm Panotec isn't just a deal; it's a calculated move to dominate the global automated packaging market.

Biotech firm R1 Therapeutics forms a star-studded advisory board to guide its promising kidney disease drug, AP306, into crucial Phase 2b trials.

A surge in seemingly innocent transaction disputes is costing businesses billions, forcing them to raise prices and tighten policies for all consumers.

As private markets boom, their manual back offices are at a breaking point. Berlin's Nomerra just raised $2M to deploy AI agents to solve this crisis.

In a market crippled by privacy rules and dying identifiers, a US tech firm's validation with France's top publisher network offers a blueprint for survival.

GenNx360’s new hire, a vet from Microsoft and GE, isn't just a personnel move. It's a sign of a seismic shift in how private equity creates value.

A new partnership between Harvard researchers and AI firm HiLabs aims to unmask the 'ghost networks' in Medicare Advantage, a crisis blocking care for millions.

Facing enterprise AI fatigue, a new partnership aims to replace bespoke projects with rapid assembly. Is a 10x faster deployment the key to unlocking real ROI?